Bronchiectasis Management in China, What We Can Learn from European Respiratory Society Guidelines.

Author: Ning WANG ¹ ; Jie-Ming QU ² ; Jin-Fu XU ¹
Author Information

1. Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.
2. Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Publication Type:Editorial
Keywords: Bronchiectasis; Challenge; China; Disease Management
MeSH: Anti-Bacterial Agents; therapeutic use; Bronchiectasis; drug therapy; epidemiology; etiology; microbiology; China; Ciliary Motility Disorders; drug therapy; epidemiology; etiology; microbiology; Connective Tissue; metabolism; Humans; Immunoglobulins; metabolism; Pseudomonas aeruginosa; drug effects; pathogenicity
From: Chinese Medical Journal 2018;131(16):1891-1893
CountryChina
Language:English